.navbar .collapse { display: block; } .mobile-nav { max-height: none !important; } @media screen and (min-width: 1200px) { .navbar #basic-navbar-nav .navbar-nav { position: static !important; } }

Multidisciplinary Management of Patients with Basal Cell Carcinoma

EP. 1: Dr. Lipson on the Current Treatment Landscape of Basal Cell Carcinoma

June 30th 2022

Evan J. Lipson, MD, discusses the current treatment landscape in locally advanced, unresectable, or metastatic basal cell carcinoma.

EP. 2: Dr. Luke on the Importance of a Multidisciplinary Approach in Basal Cell Carcinoma

June 30th 2022

Jason Luke, MD, FACP, discusses the importance of a multidisciplinary approach in basal cell carcinoma.

EP. 3: Dr. Park on the Role of Cemiplimab in Advanced Basal Cell Carcinoma

July 1st 2022

Soo Park, MD, discusses the role of cemiplimab-rwlc (Libtayo) in advanced basal cell carcinoma.

EP. 4: Multidisciplinary Management of Patients with Basal Cell Carcinoma

August 24th 2022

This publication highlights clinical perspectives on current treatment patterns in BCC, key findings from clinical trials, factors that influence clinical decision making, and opportunities for the development of novel therapies for this patient population.